Correlation Between VanEck Pharmaceutical and IShares Consumer

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both VanEck Pharmaceutical and IShares Consumer at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining VanEck Pharmaceutical and IShares Consumer into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between VanEck Pharmaceutical ETF and iShares Consumer Discretionary, you can compare the effects of market volatilities on VanEck Pharmaceutical and IShares Consumer and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in VanEck Pharmaceutical with a short position of IShares Consumer. Check out your portfolio center. Please also check ongoing floating volatility patterns of VanEck Pharmaceutical and IShares Consumer.

Diversification Opportunities for VanEck Pharmaceutical and IShares Consumer

-0.9
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between VanEck and IShares is -0.9. Overlapping area represents the amount of risk that can be diversified away by holding VanEck Pharmaceutical ETF and iShares Consumer Discretionary in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on iShares Consumer Dis and VanEck Pharmaceutical is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on VanEck Pharmaceutical ETF are associated (or correlated) with IShares Consumer. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of iShares Consumer Dis has no effect on the direction of VanEck Pharmaceutical i.e., VanEck Pharmaceutical and IShares Consumer go up and down completely randomly.

Pair Corralation between VanEck Pharmaceutical and IShares Consumer

Considering the 90-day investment horizon VanEck Pharmaceutical ETF is expected to under-perform the IShares Consumer. But the etf apears to be less risky and, when comparing its historical volatility, VanEck Pharmaceutical ETF is 1.02 times less risky than IShares Consumer. The etf trades about -0.12 of its potential returns per unit of risk. The iShares Consumer Discretionary is currently generating about 0.46 of returns per unit of risk over similar time horizon. If you would invest  8,844  in iShares Consumer Discretionary on August 30, 2024 and sell it today you would earn a total of  852.00  from holding iShares Consumer Discretionary or generate 9.63% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

VanEck Pharmaceutical ETF  vs.  iShares Consumer Discretionary

 Performance 
       Timeline  
VanEck Pharmaceutical ETF 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days VanEck Pharmaceutical ETF has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest inconsistent performance, the Etf's basic indicators remain strong and the recent confusion on Wall Street may also be a sign of long-lasting gains for the Etf traders.
iShares Consumer Dis 

Risk-Adjusted Performance

21 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in iShares Consumer Discretionary are ranked lower than 21 (%) of all global equities and portfolios over the last 90 days. In spite of rather conflicting basic indicators, IShares Consumer exhibited solid returns over the last few months and may actually be approaching a breakup point.

VanEck Pharmaceutical and IShares Consumer Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with VanEck Pharmaceutical and IShares Consumer

The main advantage of trading using opposite VanEck Pharmaceutical and IShares Consumer positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if VanEck Pharmaceutical position performs unexpectedly, IShares Consumer can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in IShares Consumer will offset losses from the drop in IShares Consumer's long position.
The idea behind VanEck Pharmaceutical ETF and iShares Consumer Discretionary pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.

Other Complementary Tools

Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.